,drug_name,section_name,gpt_output
0,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, facial pain, injection site swelling, sensation of pressure, blepharospasm, eye disorder, immunogenicity, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, hypersensitivity"
1,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
2,XEOMIN,warnings and precautions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, neuromuscular disorders, cervical dystonia, corneal exposure, corneal ulceration, ulceration, perforation, diplopia, ptosis, glabellar lines, asthenia, generalized muscle weakness, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, hypersensitivity reactions, serum sickness, urticaria, soft tissue edema, dyspnea, botulinum toxin effects, spread of toxin effect, ectropion, ecchymosis, human albumin, viral diseases transmission, Creutzfeldt-Jakob disease (CJD)"
3,QUTENZA,adverse reactions,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
4,QUTENZA,warnings and precautions,"eye and mucous membrane exposure, coughing, sneezing, irritation of eyes, airway irritation, transient increases in blood pressure, application associated pain, unintended skin exposure, aerosolization of capsaicin"
5,ZYTIGA,adverse reactions,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, chest discomfort, cardiac failure, constipation, groin pain, pyrexia, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis, death"
6,ZYTIGA,warnings and precautions,"mineralocorticoid excess, cardiovascular disease, hypertension, hypokalemia, fluid retention, adrenocortical insufficiency, hepatotoxicity, liver enzymes increase, ALT increase, AST increase, liver function test abnormalities, edema"
7,TOVIAZ,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema, airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus"
8,TOVIAZ,warnings and precautions,"Angioedema, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, headache, dizziness, death"
9,STRIBILD,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, lactic acidosis, severe hepatomegaly with steatosis, severe acute exacerbations of hepatitis B, new onset renal impairment, worsening renal impairment, bone effects, immune reconstitution syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, skin discoloration, proteinuria, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia"
10,STRIBILD,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, lactic acidosis, severe hepatomegaly with steatosis, post treatment acute exacerbation of hepatitis B, death"
11,STRIBILD,warnings and precautions,"renal impairment, acute renal failure, Fanconi syndrome, drug interactions, loss of therapeutic effect, resistance, clinically significant adverse reactions, decreases in bone mineral density (BMD), redistribution/accumulation of body fat, immune reconstitution syndrome, lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, renal tubular dysfunction, proximal renal tubulopathy, bone pain, pain in extremities, fractures, muscular pain, weakness, osteomalacia, arthralgias, hypophosphatemia, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
12,FARXIGA,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in low-density lipoprotein cholesterol (LDL-C), bladder cancer, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, increase in low-density lipoprotein cholesterol"
13,FARXIGA,warnings and precautions,"hypotension, renal function impairment, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer"
14,VICTRELIS,adverse reactions,"anemia, neutropenia, pancytopenia, hypersensitivity, fatigue, nausea, headache, dysgeusia, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
15,VICTRELIS,warnings and precautions,"Embryofetal toxicity, birth defects, fetal death, anemia, neutropenia, hypersensitivity, urticaria, angioedema, pancytopenia, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, death"
16,VIMIZIM,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity (in the presence of severe renal impairment), increased toxicity (in the presence of moderate or severe hepatic impairment), hepatotoxicity, hypersensitivity reactions, pyrexia (fever), vomiting, headache, nausea, abdominal pain, chills, fatigue"
17,VIMIZIM,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, acute respiratory illness, hypersensitivity reactions, death"
18,VIMIZIM,warnings and precautions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, hypersensitivity reactions, acute respiratory complications, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute febrile illness, respiratory illness, sleep apnea, spinal cord compression, cervical cord compression, back pain, paralysis, urinary incontinence, fecal incontinence, death"
19,BEPREVE,adverse reactions,"mild taste, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
20,BEPREVE,warnings and precautions,There are no adverse reactions to extract from this text.
21,PRISTIQ,adverse reactions,"hypersensitivity, suicidal thoughts, behaviors in adolescents and young adults, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, insomnia, anxiety, nervousness, abnormal dreams, urinary hesitation, yawning, hyperhidrosis, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, Stevens-Johnson syndrome"
22,PRISTIQ,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, renal impairment, hepatic impairment, hepatotoxicity, suicidal thoughts, suicidal behaviors, worsening of depression, emergence of suicidal thoughts and behaviors"
23,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, suicidality, agitation, hallucinations, delirium, coma, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, gastrointestinal symptoms, nausea, vomiting, diarrhea, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, dysphoric mood, irritability, sensory disturbances, paresthesia, electric shock sensations, anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, seizures, difficulty concentrating, memory impairment, weakness, unsteadiness, hallucination, syncope, respiratory arrest, death"
24,TAFINLAR,adverse reactions,"new primary malignancies, tumor promotion, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, pancreatitis, hypersensitivity, bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation"
25,TAFINLAR,warnings and precautions,"retinal vein occlusion, interstitial lung disease, new primary malignancies, cutaneous, non-cutaneous, tumor promotion, BRAF wild-type melanoma, hemorrhage, venous thromboembolism, deep vein thrombosis, pulmonary embolism, cardiomyopathy, ocular toxicities, serious febrile reactions, pyrexia, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, embryofetal toxicity, death"
26,MULTAQ,adverse reactions,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis"
27,MULTAQ,boxed warnings,"death, stroke, heart failure, decompensated heart failure, permanent atrial fibrillation"
28,MULTAQ,warnings and precautions,"cardiac rhythm abnormalities, atrial fibrillation (AF), liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogenic effects, cardiovascular death, heart failure, stroke, hepatocellular liver injury, acute liver failure, interstitial lung disease, pneumonitis, pulmonary fibrosis, QT interval prolongation, pre-renal azotemia, acute renal failure, death"
29,TANZEUM,adverse reactions,"thyroid C-cell tumors, acute pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, gastrointestinal adverse reactions, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, gamma glutamyltransferase (GGT) increase, heart rate increase"
30,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2"
31,TANZEUM,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, acute renal failure, worsening of chronic renal failure, nausea, vomiting, diarrhea, dehydration"
32,BELEODAQ,adverse reactions,"hematologic toxicity, infection, hepatotoxicity, tumor lysis syndrome, gastrointestinal toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, increased creatinine, multi-organ failure, death, hepatic failure, ventricular fibrillation, febrile neutropenia"
33,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, pneumonia, sepsis, hepatotoxicity, tumor lysis syndrome, embryo-fetal toxicity, nausea, vomiting, diarrhea, death"
34,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, QT interval prolongation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, peripheral motor neuropathy, polyneuropathy, peripheral sensory neuropathy, paresthesia, thrombocytopenia, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis, neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
35,HALAVEN,warnings and precautions,"neutropenia, peripheral neuropathy, embryo-fetal toxicity, QT prolongation, severe neutropenia, febrile neutropenia, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, motor neuropathy, sensory neuropathy, fetal harm, teratogenicity"
36,XIAFLEX,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, tendon ruptures, serious injury, corporal rupture, penile fracture, severe penile hematoma, penile ecchymoses, penile detumescence, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in extremity, tenderness, injection site swelling, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, penile hematoma, penile swelling, penile pain, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
37,XIAFLEX,boxed warnings,"corporal rupture, penile fracture, serious penile injury, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, severe penile hematoma"
38,XIAFLEX,warnings and precautions,"tendon rupture, serious injury, finger injury, hand injury, ligament damage, skin laceration, corporal rupture, penile fracture, hypersensitivity reactions, anaphylaxis, abnormal coagulation, pulley rupture, ligament injury, complex regional pain syndrome, CRPS, sensory abnormality, penile ecchymoses, penile hematoma, penile detumescence, severe penile hematoma, bleeding, ecchymosis, contusion, injection site hemorrhage, pruritus"
39,CIMZIA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, acute bronchitis, fatigue, pharyngitis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis"
40,CIMZIA,boxed warnings,"serious infections, malignancy, hospitalization, death, tuberculosis, reactivation of latent tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, opportunistic pathogens, Legionella, Listeria, sepsis, lymphoma, other malignancies"
41,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, tuberculosis, hepatosplenic T-cell lymphoma, leukemia, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, neurologic reactions, seizure disorder, optic neuritis, peripheral neuropathy, hematological reactions, aplastic anemia, leukopenia, thrombocytopenia, autoimmunity, immunosuppression, death"
42,GRANIX,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, splenic rupture, acute respiratory distress syndrome, serious allergic reactions, complications in patients with sickle cell disease, capillary leak syndrome, potential for tumor growth stimulatory effects on malignant cells, bone pain, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia"
43,GRANIX,warnings and precautions,"splenic rupture, acute respiratory distress syndrome (ARDS), allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, sickle cell crisis, capillary leak syndrome (CLS), death"
44,TUDORZA,adverse reactions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
45,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, anaphylaxis, angioedema, bronchospasm, urticaria, rash, itching"
46,JEVTANA,adverse reactions,"Bone marrow suppression, hypersensitivity reactions, gastrointestinal adverse reactions, renal failure, embryo-fetal toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, febrile neutropenia, infections, ventricular fibrillation, cerebral hemorrhage, arrhythmia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, sepsis, septic shock, gastritis, intestinal obstruction, death"
47,JEVTANA,boxed warnings,"neutropenia, neutropenic deaths, death, hypersensitivity, generalized rash, erythema, hypotension, bronchospasm"
48,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, anemia, thrombocytopenia, pancytopenia, hypersensitivity, gastrointestinal disorders, nausea, vomiting, diarrhea, gastrointestinal hemorrhage, gastrointestinal perforation, neutropenic enterocolitis, renal failure, death, fetal harm"
49,ILARIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, serious infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, intra-abdominal abscess, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, pharyngitis, tonsillitis, urinary tract infection, viral infection, rhinitis, bronchitis, weight increased, musculoskeletal pain, vertigo, hypersensitivity reactions"
50,ILARIS,warnings and precautions,"serious infections, upper respiratory tract infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, opportunistic infections, immunosuppression, malignancies, hypersensitivity reactions, anaphylactic reactions, immunizations, live vaccine administration, ineffective vaccinations, macrophage activation syndrome (MAS), death"
51,AMPYRA,adverse reactions,"Seizures, anaphylaxis, urinary tract infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain"
52,AMPYRA,warnings and precautions,"seizures, anaphylaxis, severe allergic reactions, respiratory compromise, urticaria, angioedema, urinary tract infections"
53,SIRTURO,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, increased mortality, QT prolongation, hepatotoxicity, drug interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, death"
54,SIRTURO,boxed warnings,"increased mortality, QT prolongation, death"
55,SIRTURO,warnings and precautions,"QT prolongation, ventricular arrhythmia, QTcF interval > 500 ms, hepatotoxicity, increased mortality, death, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, hypokalemia, hypocalcemia, hypomagnesemia, clinically significant ventricular arrhythmia, syncope, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, aminotransferase elevations, bilirubin elevation"
56,ADREVIEW,adverse reactions,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
57,ADREVIEW,warnings and precautions,"hypersensitivity reactions, anaphylactic treatment measures, hypersensitivity treatment measures, serious reactions, severe renal impairment, radiation exposure, iodine 123 accumulation, thyroid neoplasia, hypertension, death"
58,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
59,ARCAPTA,boxed warnings,"asthma-related death, death"
60,ARCAPTA,warnings and precautions,"acute COPD deterioration, acute symptoms, cardiovascular effects, death, immediate hypersensitivity reactions, paradoxical bronchospasm, cardiovascular disorders, convulsive disorders, thyrotoxicosis, sympathomimetic drugs sensitivity, hypokalemia, hyperglycemia"
61,INTELENCE,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, severe skin reactions, hypersensitivity reactions, rash, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, rhabdomyolysis, toxic epidermal necrolysis, death"
62,INTELENCE,warnings and precautions,"severe skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 rash, Grade 4 rash, fever, general malaise, fatigue, muscle aches, joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, fat redistribution, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia, tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death"
63,PICATO,adverse reactions,"ophthalmic adverse reaction, hypersensitivity reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
64,PICATO,warnings and precautions,"eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, local skin reactions, vesiculation, pustulation, erosion, ulceration, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis, erythema, crusting, swelling"
65,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure"
66,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, image interpretation errors, false positives, radiation risk"
67,POTIGA,adverse reactions,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhidrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy"
68,POTIGA,boxed warnings,"retinal abnormalities, vision loss, abnormal visual acuity, decreased visual acuity, damage to the photoreceptors, retinal pigmentary abnormalities"
69,POTIGA,warnings and precautions,"urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts, suicidal behaviors, depression, mood changes, withdrawal seizures, retinal abnormalities, vision loss, hydronephrosis, renal function impairment, blue skin discoloration, grey-blue skin discoloration, brown skin discoloration, perivascular pigmentation, retinal pigment epithelium clumping, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, fluorescein angiography abnormalities, visual field testing sensitivity diminishment"
70,BREO,adverse reactions,"asthma-related death, death, Candida albicans infection, increased risk of pneumonia, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, oropharyngeal candidiasis, influenza, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, pneumonia, bronchitis, sinusitis, cough, oropharyngeal pain, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, pharyngitis, pyrexia, arthralgia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, pharyngitis, rhinitis, arthralgia, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, pneumonia, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness"
71,BREO,boxed warnings,"asthma-related death, asthma-related hospitalization, death"
72,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, Candida albicans infection, pneumonia, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, anaphylaxis, angioedema, rash, urticaria, cardiovascular effects, arrhythmias, supraventricular tachycardia, extrasystoles, electrocardiographic changes, QTc interval prolongation, ST segment depression, bone mineral density reduction, glaucoma, increased intraocular pressure, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth velocity reduction, death"
73,DOTAREM,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, renal impairment, hepatic impairment, hepatotoxicity, nephrogenic systemic fibrosis (NSF), hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, increased serum creatinine, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, increased lacrimation, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis"
74,DOTAREM,boxed warnings,"Nephrogenic systemic fibrosis (NSF), fatal fibrosis, chronic severe kidney disease, acute kidney injury, reduced renal function, death"
75,DOTAREM,warnings and precautions,"nephrogenic systemic fibrosis, hypersensitivity, anaphylactoid reactions, anaphylactic reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, acute kidney injury, extravasation, injection site reactions"
76,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
77,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, death, hypoglycemia, arthralgia"
78,EYLEA,adverse reactions,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal detachment, retinal tear, endophthalmitis"
79,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increase in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
80,TECFIDERA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albuminuria, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia"
81,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy (PML), lymphopenia, flushing, death"
82,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, malignancies, extravasation injury, pyrexia, nausea, vomiting, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, hypertension, hypertensive crisis, hypersensitivity, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, mucosal inflammation, bilirubin elevations, increased AST, increased ALT, creatinine levels changes, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal distension, chills, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, nasopharyngitis, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, pruritus, dry skin, night sweats, hyperhidrosis, hypotension, hyperglycemia, hyponatremia, hypocalcemia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
83,TREANDA,warnings and precautions,"myelosuppression, death, infections, fever, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), other malignancies, extravasation injury, embryo-fetal toxicity"
84,ELIQUIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hypersensitivity reactions, syncope, nausea, anemia, contusion, hemorrhage, postprocedural hemorrhage, transaminases increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, respiratory disorders, epistaxis, gastrointestinal hemorrhage, hematochezia, hepatobiliary disorders, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, renal disorders, hematuria, injury, poisoning, procedural complications, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, hematemesis, melena, anal hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
85,ELIQUIS,boxed warnings,"thrombotic events, spinal hematoma, epidural hematoma, paralysis"
86,ELIQUIS,warnings and precautions,"bleeding, fatal bleeding, thrombotic events, stroke, blood loss, pathological bleeding, hemorrhage, epidural hematoma, spinal hematoma, paralysis, neurological impairment, death"
87,BOSULIF,adverse reactions,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT increase, SGOT/AST increase, lipase increase, phosphorus low, total bilirubin increase, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, hepatotoxicity, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption"
88,BOSULIF,warnings and precautions,"gastrointestinal toxicity, diarrhea, nausea, vomiting, abdominal pain, myelosuppression, thrombocytopenia, anemia, neutropenia, hepatic toxicity, drug induced liver injury, ALT elevation, AST elevation, fluid retention, pericardial effusion, pleural effusion, pulmonary edema, peripheral edema, renal toxicity, estimated glomerular filtration rate decline, embryofetal toxicity"
89,GILENYA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, bronchitis, herpes zoster, tinea versicolor, bradycardia, migraine, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas"
90,GILENYA,warnings and precautions,"bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), pulmonary function test decrease, liver injury, blood pressure increase, immune system effects, death, herpes zoster, influenza, sinusitis, pneumonia, herpes simplex encephalitis, disseminated varicella zoster, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus, atrioventricular blocks, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, third-degree AV block, AV block with junctional escape, transient asystole, syncope, herpetic infections, disseminated primary herpes zoster, herpes simplex infections, encephalitis, varicella zoster virus antibody testing, vaccination, JC virus, visual disturbances, forced expiratory volume, diffusion lung capacity for carbon monoxide (DLCO), dyspnea, liver transaminases elevation, jaundice, dark urine, fetal harm, systolic pressure increase, diastolic pressure increase, hypertension, lymphocyte count decrease"
91,BENLYSTA,adverse reactions,"mortality, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, cystitis, leukopenia, gastroenteritis viral, fatal anaphylaxis, death"
92,BENLYSTA,warnings and precautions,"mortality, serious infections, fatal infections, progressive multifocal leukoencephalopathy (PML), hypersensitivity reactions, anaphylaxis, depression, suicidality, malignancies, non-melanoma skin cancers, infusion reactions, bradycardia, myalgia, rash, urticaria, hypotension, headache, nausea, skin reactions, psychiatric events, insomnia, anxiety, live vaccine risks, death"
93,XALKORI,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, neuropathy, rash, renal cyst, syncope, neutropenia, lymphopenia, hypophosphatemia, ALT elevation, AST elevation, hypokalemia, hepatic failure, acute respiratory distress syndrome, arrhythmia, pneumonia, respiratory failure, sepsis, weight increased, pain in extremity, muscle spasm, dizziness, headache, fatigue, dysesthesia, gait disturbance, hypoesthesia, muscular weakness, neuralgia, peripheral neuropathy, parasthesia, peripheral sensory neuropathy, polyneuropathy, burning sensation in skin, death"
94,XALKORI,warnings and precautions,"hepatotoxicity, fatal hepatotoxicity, death, interstitial lung disease (ILD), pneumonitis, QT interval prolongation, bradycardia, severe visual loss, embryofetal toxicity"
95,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation"
96,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, heart failure exacerbation, rebound hypertension"
97,LUMIZYME,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, local swelling, diarrhea, pruritus, edema, peripheral, rash papular, flu-like illness, chills, arthralgia, pain, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions"
98,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload, death"
99,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, acute cardiorespiratory failure, cardiac arrhythmia, sudden cardiac death, death, necrotizing skin lesions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition, anaphylactic shock, cardiac arrest, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, urticaria, chest discomfort/pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension/increased blood pressure, flushing/feeling hot, erythema, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia"
100,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
101,CERDELGA,warnings and precautions,"ECG changes, cardiac arrhythmias, prolongation of the PR interval, prolongation of the QTc interval, prolongation of the QRS interval"
102,NEURACEQ,adverse reactions,"erythema, irritation, pain"
103,NEURACEQ,warnings and precautions,"image interpretation errors, false positives, radiation exposure, risk for image misinterpretation, errors, brain atrophy, motion artifacts, increased risk of cancer"
104,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, back pain, arthralgia, nasopharyngitis, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, death"
105,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, cellulitis, dermatologic reactions, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover, death"
106,FANAPT,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, anemia, iron deficiency anemia, leukopenia, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, congestive heart failure, acute heart failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, allergic conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, conjunctival hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, general edema, pitting edema, edema due to cardiac disease, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation."
107,FANAPT,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, death"
108,FANAPT,warnings and precautions,"death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, Dyslipidemia, Weight Gain, Seizures, Orthostatic hypotension, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive impairment, motor impairment, somnolence, sedation"
109,FULYZAQ,adverse reactions,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
110,FULYZAQ,warnings and precautions,infectious diarrhea
111,EOVIST,adverse reactions,"nephrogenic systemic fibrosis, hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions, dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders, fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
112,EOVIST,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, nephrogenic systemic fibrosis, fibrosis, death"
113,EOVIST,warnings and precautions,"nephrogenic systemic fibrosis, hypersensitivity reactions, anaphylactoid reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, shock, acute kidney injury, extravasation, injection site reactions, myocyte necrosis, inflammation, interference with laboratory tests, interference with visualization of liver lesions, death"
114,ONFI,adverse reactions,"'somnolence, sedation, potentiation of sedation, central nervous system depressants, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, constipation, pyrexia, lethargy, drooling, ataxia, aggression, fatigue, insomnia, vomiting, dysphagia, irritability, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, somnolence, sedation, lethargy, drooling, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema'"
115,ONFI,warnings and precautions,"somnolence, sedation, CNS depression, withdrawal symptoms, serious dermatological reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, depression, mood changes, self-harm"
116,COMETRIQ,adverse reactions,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, cardiac arrest, respiratory failure, death"
117,COMETRIQ,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, renal impairment, hepatic impairment, hepatotoxicity, gastrointestinal perforations, fistula formation, hemorrhage, hemoptysis, gastrointestinal hemorrhage, death"
118,COMETRIQ,warnings and precautions,"thrombotic events, myocardial infarction, cerebral infarction, arterial thromboembolism, wound complications, dehiscence, hypertension, hypertensive crisis, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, nephrotic syndrome, reversible posterior leukoencephalopathy syndrome, gastrointestinal perforations, fistulas, hemorrhage, hemoptysis, death"
119,NULOJIX,adverse reactions,"PTLD, CNS PTLD, malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-melanoma skin cancer, progressive multifocal leukoencephalopathy (PML), fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, infusion reactions, hypotension, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), dyslipidemia, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, hypophosphatemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death (due to fatal cases of PML)"
120,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder, malignancies, serious infections, increased susceptibility to infection, graft loss, death"
121,NULOJIX,warnings and precautions,"post-transplant lymphoproliferative disorder, CNS involvement, neurological signs, cognitive signs, behavioral signs, other malignancies, progressive multifocal leukoencephalopathy, PML, serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, polyoma virus-associated nephropathy, PVAN, BK virus infection, kidney graft loss, liver transplant, graft loss, death, acute rejection, graft loss, corticosteroid minimization, immunizations, live vaccines, death"
122,GILOTRIF,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, diarrhea, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, rash, dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity, ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, gastrointestinal disorders, cheilitis, skin and subcutaneous tissue disorders, infections and infestations, cystitis, metabolism and nutrition disorders, respiratory disorders, thoracic disorders, mediastinal disorders, epistaxis, rhinorrhea, investigations, weight decreased, general disorders, administration site conditions, pyrexia, eye disorders, conjunctivitis, laboratory abnormalities, alanine aminotransferase increased, hypokalemia, aspartate aminotransferase increased, pancreatitis, death"
123,GILOTRIF,warnings and precautions,"diarrhea, dehydration, renal failure, bullous skin disorders, exfoliative skin disorders, interstitial lung disease (ILD), hepatic toxicity, death, keratitis, embryofetal toxicity"
124,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
125,DATSCAN,warnings and precautions,"hypersensitivity reactions, skin erythema, pruritis, anaphylactic treatment measures, hypersensitivity treatment measures, thyroid accumulation, thyroid neoplasia"
126,KALBITOR,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, seroconversion, anti-ecallantide antibodies, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies."
127,KALBITOR,boxed warnings,"Adverse reactions: anaphylaxis, hypersensitivity reactions, hereditary angioedema"
128,KALBITOR,warnings and precautions,"hypersensitivity reactions, anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
129,APTIOM,adverse reactions,"suicidal behavior, ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms, DRESS, multiorgan hypersensitivity, anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, drug induced liver injury, abnormal thyroid function tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, ear and labyrinth disorders, vertigo, eye disorders, diplopia, blurred vision, visual impairment, gastrointestinal disorders, nausea, vomiting, diarrhea, constipation, abdominal pain, gastritis, general disorders and administration site conditions, fatigue, asthenia, gait disturbance, peripheral edema, infections and infestations, urinary tract infections, injury, poisoning and procedural complications, fall, metabolism and nutrition disorders, hyponatremia, nervous system disorders, dizziness, somnolence, headache, ataxia, balance disorder, tremor, dysarthria, memory impairment, nystagmus, psychiatric disorders, depression, insomnia, respiratory, thoracic and mediastinal disorders, cough, skin and subcutaneous tissue disorders, rash, vascular disorders, hypertension"
130,APTIOM,warnings and precautions,"suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, drug induced liver injury, abnormal thyroid function tests"
131,DUAVEE,adverse reactions,"cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis"
132,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), blood clots, cancer of the uterus, heart disease, heart attacks, dementia, strokes, blood clots, gallbladder problems, high blood pressure, increased fats in the blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of the mouth or tongue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
133,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, thyroid function, dementia, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance"
134,KALYDECO,adverse reactions,"transaminase elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, serious adverse reactions, increased hepatic enzymes, hypoglycemia, rhinitis, bacteria in sputum, arthralgia, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
135,KALYDECO,warnings and precautions,"Elevated transaminases, cataracts"
136,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, hypertension, fatigue, nausea, injection site reaction, injection site haemorrhage, injection site irritation, injection site pain, anxiety, back pain, claustrophobia, dizziness, feeling cold, chills, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
137,AMYVID,warnings and precautions,"Image interpretation errors, false negatives, radiation risk, cancer"
138,TIVICAY,adverse reactions,"hypersensitivity reactions, serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, treatment-emergent adverse drug reactions, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, rash, insomnia, depression, abnormal dreams, dizziness, headache, nausea, diarrhea, fatigue, vertigo"
139,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, life-threatening reaction, transaminase elevations, hepatotoxicity, immune reconstitution syndrome, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia, tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome, death"
140,ULESFIA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity (in the presence of severe renal impairment), increased toxicity (in the presence of moderate or severe hepatic impairment), hepatotoxicity, ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
141,ULESFIA,warnings and precautions,"neonatal toxicity, gasping syndrome, metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, contact dermatitis"
142,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
143,TRULICITY,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, renal impairment, hepatic impairment, hepatotoxicity, thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, severe gastrointestinal disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, gastrointestinal adverse reactions, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, documented symptomatic hypoglycemia, severe hypoglycemia, heart rate increase, tachycardia, sinus tachycardia, immunogenicity, anti-drug antibodies, dulaglutide-neutralizing antibodies, antibodies against native GLP-1, systemic hypersensitivity, severe urticaria, systemic rash, facial edema, lip swelling, injection-site reactions, injection-site rash, erythema, PR interval prolongation, first degree atrioventricular block, amylase increase, lipase increase"
144,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
145,TRULICITY,warnings and precautions,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, acute renal failure, worsening of chronic renal failure, severe gastrointestinal reactions, gastrointestinal adverse reactions, severe gastroparesis"
146,TEFLARO,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, hypersensitivity reactions, Clostridium difficile-associated diarrhea, direct Coombs' test seroconversion, diarrhea, nausea, rash, serious adverse reactions, discontinuation, gastrointestinal disorders, increased transaminases, metabolism and nutrition disorders, hypokalemia, skin and subcutaneous tissue disorders, vascular disorders, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, cardiac disorders, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
147,TEFLARO,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, Direct Coombs' test seroconversion, hemolytic anemia, drug-induced hemolytic anemia, drug-resistant bacteria, death"
148,JARDIANCE,adverse reactions,"hypotension, renal function impairment, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, dyslipidemia, arthralgia, nausea, thirst, volume depletion, increased urination, polyuria, pollakiuria, nocturia, dehydration, orthostatic hypotension, syncope, serum creatinine increase, eGFR decrease, phimosis, asymptomatic bacteriuria, cystitis, hematocrit increase"
149,JARDIANCE,warnings and precautions,"hypotension, renal function impairment, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
150,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure (some fatal), jaundice, serious cases of abnormal liver function test results, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, death"
151,ULORIC,warnings and precautions,"gout flare, cardiovascular events, cardiovascular thromboembolic events, cardiovascular deaths, non-fatal myocardial infarctions, non-fatal strokes, hepatic failure, death, hepatic effects, transaminase elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe drug-induced liver injury"
152,KYPROLIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, cardiac toxicities, acute renal failure, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocyte, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, pneumonia, respiratory tract infection, pulmonary embolism, constipation, asthenia, nasopharyngitis, bronchitis, hypocalcemia, hyperglycemia, muscle spasms, insomnia, rash, embolic and thrombotic events, venous, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, decreased appetite, hypercalcemia, back pain, arthralgia, pain in extremity, musculoskeletal pain, headache, dizziness, peripheral neuropathies NEC, insomnia, dyspnea, epistaxis, renal failure, hypertension, dehydration, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), posterior reversible encephalopathy syndrome (PRES), death"
153,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, myocardial ischemia, death, acute renal failure, tumor lysis syndrome, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pulmonary hypertension, dyspnea, hypertension, hypertensive crisis, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, embryo-fetal toxicity"
154,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, immune-mediated adverse reactions, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, gastrointestinal disorders, skin and subcutaneous tissue disorders, general disorders and administration site conditions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), hypersensitivity, anaphylaxis, death"
155,YERVOY,boxed warnings,"Enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy, death"
156,YERVOY,warnings and precautions,"immune-mediated reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, immune-mediated enterocolitis, immune-mediated dermatitis, immune-mediated neuropathies, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy, encephalitis, myositis, polymyositis, ocular myositis, Guillain-Barre syndrome, peripheral motor neuropathy, Stevens-Johnson syndrome, toxic epidermal necrolysis, death"
157,GADAVIST,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, nephrogenic systemic fibrosis, hypersensitivity reactions, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, hypersensitivity, anaphylactoid reactions, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
158,GADAVIST,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, nephrogenic systemic fibrosis, fibrosis, chronic severe kidney disease, acute kidney injury, death"
159,GADAVIST,warnings and precautions,"nephrogenic systemic fibrosis, anaphylactic reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, death, acute kidney injury, extravasation, injection site reactions, overestimation of malignant disease"
160,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache"
161,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, drug interactions, suicidal ideation, suicidal behavior, death"
162,DYSPORT,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, cervical dystonia, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, blood glucose increase, electrocardiographic findings, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, injection site reaction, eyelid ptosis, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, gait disturbance, hypertonia, sensation of heaviness"
163,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
164,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, neuromuscular disorder exacerbation, Creutzfeldt-Jakob disease risk, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
165,FIRAZYR,adverse reactions,"'peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, immunogenicity, hypersensitivity, anaphylactic reactions'"
166,FIRAZYR,warnings and precautions,laryngeal attacks
167,INVOKANA,adverse reactions,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C, increased non-HDL-C, increased hemoglobin, decreased bone mineral density, urinary tract infections, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reaction, polymorphic light eruption, sunburn, volume depletion-related adverse reactions, hypotension, postural dizziness, orthostatic hypotension, syncope, dehydration, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, candidal balanitis, balanoposthitis, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in hemoglobin, decreases in bone mineral density"
168,INVOKANA,warnings and precautions,"hypotension, renal function impairment, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
169,XTANDI,adverse reactions,"seizure, asthenia, fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness, vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract infection, lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, sepsis, fall-related injuries, hypertensive crisis"
170,XTANDI,warnings and precautions,seizure
171,AFINITOR,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, non-infectious pneumonitis, angioedema, oral ulceration, renal failure, impaired wound healing, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, anemia, leukopenia, thrombocytopenia, lymphopenia, increased aspartate transaminase (AST), increased alanine transaminase (ALT), hypertriglyceridemia, death, vomiting, constipation, dry mouth, pyrexia, weight decreased, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, epistaxis, pruritus, alopecia, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, glucose increased, cholesterol increased, triglycerides increased, albumin decreased, potassium decreased, creatinine increased, renal angiomyolipoma, SEGA, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH) levels, increased blood follicle stimulating hormone (FSH) levels, hypersensitivity, ovarian cyst, angioedema, acne, muscle spasms, dizziness, hypertension, irregular menstruation, diabetes mellitus, abdominal pain, nausea, vomiting, constipation, dry mouth, peripheral edema, upper respiratory tract infection, arthralgia, cough, acne, amenorrhea, menorrhagia, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood LH levels, increased blood FSH levels, hypersensitivity, ovarian cyst, pneumonitis, anxiety, aggression, behavioral disturbance, rash, acne, nausea, pain in extremity, insomnia, pneumonia, epistaxis, hypersensitivity, increased blood LH levels, pneumonitis, elevated partial thromboplastin time, neutropenia, elevated aspartate transaminase (AST), hypertriglyceridemia, elevated alanine transaminase (ALT), hypophosphatemia, cellulitis, hyperglycemia, elevated creatinine, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy."
172,AFINITOR,warnings and precautions,"non-infectious pneumonitis, infections, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, impaired wound healing, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, laboratory test alterations, serum creatinine elevation, urinary protein increase, blood glucose elevation, lipid elevation, hemoglobin decrease, neutrophils decrease, platelets decrease, embryo-fetal toxicity, death"
173,ENTEREG,adverse reactions,dyspepsia
174,ENTEREG,boxed warnings,myocardial infarction
175,ENTEREG,warnings and precautions,"myocardial infarction, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, end-stage renal disease, complete gastrointestinal obstruction, pancreatic anastomosis, gastric anastomosis"
176,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, malaria, nasopharyngitis, Plasmodium falciparum infection, rhinitis, aspartate aminotransferase increased, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions, bullous eruption."
177,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, electrolyte imbalance, decreased efficacy, recrudescence, hepatic impairment, renal impairment, Plasmodium vivax infection"
178,DALVANCE,adverse reactions,"nausea, vomiting, diarrhea, headache, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma"
179,DALVANCE,warnings and precautions,"hypersensitivity reactions, anaphylactic reactions, skin reactions, rapid intravenous infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea, CDAD, flushing of the upper body, urticaria, pruritus, rash, liver test abnormalities, increased morbidity, mortality, fluid and electrolyte management issues, protein supplementation requirements, surgical evaluation necessity, drug-resistant bacteria development"
180,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, abdominal pain/discomfort, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
181,FERRIPROX,boxed warnings,"Adverse reactions: agranulocytosis, neutropenia, infections, death"
182,FERRIPROX,warnings and precautions,"agranulocytosis, neutropenia, infection, fetal harm, embryofetal death, malformations, increased ALT, increased AST, decreased plasma zinc concentrations, death"
183,PRADAXA,adverse reactions,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, dyspepsia, nausea, upper abdominal pain, diarrhea, major bleeding, intracranial hemorrhage, hemorrhagic stroke, gastrointestinal bleeding, fatal bleeding, ICH, non-intracranial fatal bleed, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, clinical myocardial infarction, abdominal pain upper, abdominal discomfort, epigastric discomfort, gastritis, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, angioedema, thrombocytopenia, esophageal ulcer, death"
184,PRADAXA,boxed warnings,"thrombotic events, spinal hematoma, epidural hematoma, paralysis"
185,PRADAXA,warnings and precautions,"bleeding, fatal bleeding, thrombotic events, blood loss, hypotension, pathological bleeding, spinal hematoma, paralysis, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, pericardial effusions, death"
186,VORAXAZE,adverse reactions,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea, vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
187,VORAXAZE,warnings and precautions,"serious allergic reactions, anaphylactic reactions"
188,HORIZANT,adverse reactions,"'somnolence, sedation, dizziness, RLS, PHN, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase'"
189,HORIZANT,warnings and precautions,"driving impairment, somnolence, sedation, dizziness, suicidal thoughts, behaviors, suicidal ideation, depression, mood changes, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, tumors, breast cancer, brain tumors, lung cancer, adrenal tumor, non-Hodgkin's lymphoma, endometrial carcinoma in situ, prostate cancer"
190,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, gastroenteritis viral, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, Non-arteritic anterior ischemic optic neuropathy (NAION)"
191,STENDRA,warnings and precautions,"hypotension, prolonged erection, priapism, sudden loss of vision, NAION, sudden decrease or loss of hearing, tinnitus, dizziness, symptomatic hypotension, orthostatic signs and symptoms, headache, bleeding disorders, peptic ulceration"
192,ADCETRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, abdominal pain, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), toxic epidermal necrolysis, Stevens-Johnson syndrome, septic shock, supraventricular arrhythmia, urinary tract infection, pneumonia, hepatotoxicity, acute respiratory distress syndrome, paraesthesia, infusion related reactions, non-infectious pulmonary toxicity"
193,ADCETRIS,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, progressive multifocal leukoencephalopathy (PML), JC virus infection, death"
194,ADCETRIS,warnings and precautions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, neutropenia, thrombocytopenia, anemia, febrile neutropenia, infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, hepatotoxicity, renal impairment, hepatic impairment, progressive multifocal leukoencephalopathy, pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome, serious dermatologic reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, embryo-fetal toxicity, fetal harm, death"
195,ZERBAXA,adverse reactions,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis, death"
196,ZERBAXA,warnings and precautions,"decreased efficacy, hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, drug-resistant bacteria"
197,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
198,ZYDELIG,boxed warnings,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death"
199,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, death"
200,SIMPONI,adverse reactions,"serious infections, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, TB, invasive fungal infections, malignancies, lymphoma, non-melanoma skin cancer, NMSC, melanoma, liver enzyme elevations, hepatic reactions, acute liver failure, alanine aminotransferase increased, aspartate aminotransferase increased, autoimmune disorders, lupus-like syndrome, autoantibodies, ANA-positive, anti-dsDNA antibodies, administration reactions, infusion reaction, rash, immunogenicity, antibodies to SIMPONI ARIA, neutralizing antibodies, infections and infestations, upper respiratory tract infection, viral infections, bacterial infections, bronchitis, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, vascular disorders, hypertension, skin and subcutaneous disorders, rash, skin exfoliation, bullous skin reactions, general disorders and administration site conditions, pyrexia, blood and lymphatic disorders, leukopenia, nervous system disorders, dizziness, paresthesia, gastrointestinal disorders, constipation, immune system disorders, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease"
201,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis, bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, sepsis, latent tuberculosis, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, Legionella, Listeria, malignancy, lymphoma"
202,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, tuberculosis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, sepsis, congestive heart failure, central nervous system demyelinating disorders, multiple sclerosis, peripheral demyelinating disorders, Guillain-Barre syndrome, optic neuritis, peripheral demyelinating polyneuropathy, hematologic cytopenias, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, death"
203,BLINCYTO,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, cytokine release syndrome, neurological toxicities, neutropenia, febrile neutropenia, effects on ability to drive and use machines, elevated liver enzymes, leukoencephalopathy, preparation and administration errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, increased weight, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, increased liver enzymes, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, death"
204,BLINCYTO,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, cytokine release syndrome, neurological toxicities, death"
205,BLINCYTO,warnings and precautions,"cytokine release syndrome, infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation, capillary leak syndrome, hemophagocytic lymphohistiocytosis, macrophage activation syndrome, neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion, disorientation, coordination and balance disorders, infections, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, tumor lysis syndrome, neutropenia, febrile neutropenia, elevated liver enzymes, leukoencephalopathy, preparation and administration errors, death"
206,NATAZIA,adverse reactions,"'serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, migraines, menstrual disorders, vomiting, acne, mood changes, increased weight, metrorrhagia, menorrhagia, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis'"
207,NATAZIA,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, serious cardiovascular events"
208,NATAZIA,warnings and precautions,"thrombotic event, thromboembolism, venous thromboembolism, arterial thromboses, strokes, myocardial infarctions, retinal vein thrombosis, carcinoma, breast cancer, cervical cancer, intraepithelial neoplasia, liver disease, jaundice, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, high blood pressure, hypertension, gallbladder disease, carbohydrate metabolic effects, lipid metabolic effects, glucose tolerance, dyslipidemia, hypertriglyceridemia, pancreatitis, headache, migraine, cerebrovascular event, bleeding irregularities, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, depression, hereditary angioedema, chloasma, chloasma gravidarum, death (due to rupture of hepatic adenomas causing intra-abdominal hemorrhage)"
209,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
210,DIFICID,warnings and precautions,"systemic infections, acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, drug-resistant bacteria"
211,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema"
212,EDARBI,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, renal impairment, hepatic impairment, hepatotoxicity, fetal toxicity, injury, death"
213,EDARBI,warnings and precautions,"fetal toxicity, fetal renal function reduction, fetal and neonatal morbidity, death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, hypotension, impaired renal function, oliguria, progressive azotemia, acute renal failure, serum creatinine increase, blood urea nitrogen increase"
214,IMBRUVICA,adverse reactions,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, stomatitis, dyspepsia, sinusitis, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, headache, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, hyperuricemia, renal failure, laceration, anxiety, insomnia, hypertension, vision blurred, contusion, pruritus, arthropathy, skin cancer, hypersensitivity reactions, anaphylactic shock, urticaria, angioedema, death"
215,IMBRUVICA,warnings and precautions,"hemorrhage, bleeding, bruising, petechiae, infections, progressive multifocal leukoencephalopathy (PML), cytopenias, neutropenia, thrombocytopenia, anemia, atrial fibrillation, atrial flutter, second primary malignancies, non-skin carcinomas, non-melanoma skin cancer, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights, death"
216,DUREZOL,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal thinning, scleral thinning, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritus, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, scleral hyperemia, uveitis, blurred vision, eye irritation, headache, increased IOP, limbal hyperemia, anterior chamber flare, dry eye, iridocyclitis"
217,DUREZOL,warnings and precautions,"'intraocular pressure increase, glaucoma, optic nerve damage, defects in visual acuity, defects in fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, bleb formation, corneal thinning, scleral thinning, corneal perforation, scleral perforation, bacterial infections, secondary ocular infections, viral infections, herpes simplex exacerbation, fungal infections, corneal ulceration, fungus invasion'"
218,ZYKADIA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, severe or persistent gastrointestinal toxicity, interstitial lung disease, pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, paresthesia, muscular weakness, gait disturbance, peripheral neuropathy, hypoesthesia, peripheral sensory neuropathy, dysesthesia, neuralgia, peripheral motor neuropathy, hypotonia, polyneuropathy, vision disorder, vision impairment, blurred vision, photopsia, accommodation disorder, presbyopia, reduced visual acuity, prolonged QT interval, hemoglobin decreased, alanine transaminase increased, aspartate transaminase increased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin increased, death."
219,ZYKADIA,warnings and precautions,"gastrointestinal toxicity, diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, interstitial lung disease (ILD), pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, embryofetal toxicity, death"
220,CHOLINE,adverse reactions,injection site reaction
221,CHOLINE,warnings and precautions,"imaging errors, allergic reactions, radiation risk, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, interference with imaging, anaphylaxis, cancer risk"
222,ERWINAZE,adverse reactions,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperlipidemia, ketoacidosis, CNS events"
223,ERWINAZE,warnings and precautions,"hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
224,SAPHRIS,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hypersensitivity reactions, oral ulcers, blisters, peeling, sloughing, inflammation, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT interval prolongation, hyperprolactinemia, seizures, cognitive impairment, motor impairment, body temperature regulation, suicide, dysphagia, akathisia, oral hypoesthesia, somnolence, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, constipation, dry mouth, salivary hypersecretion, stomach discomfort, vomiting, irritability, insomnia, hypertension, anxiety, depression, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, tachycardia, heart rate increased, glossodynia, muscle strain, hyperinsulinemia, ALT increased, AST increased, dehydration, myalgia, parkinsonism, suicidal ideation, anger, edema peripheral, dystonia, dysarthria, diplopia, vision blurred, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, choking, oropharyngeal muscular dysfunction, hypoesthesia"
225,SAPHRIS,boxed warnings,Adverse reactions: death
226,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hyperglycemia, dyslipidemia, weight gain, hypersensitivity reactions, anaphylaxis, angioedema, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT prolongation, seizures, cognitive impairment, motor impairment, suicide, dysphagia, aspiration, death"
227,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
228,CARBAGLU,warnings and precautions,"Hyperammonemia, brain injury, death"
229,PROMACTA,adverse reactions,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, cataract, abdominal pain, toothache, vitamin D deficiency, thrombotic microangiopathy, acute renal failure"
230,PROMACTA,boxed warnings,Adverse reactions: hepatic decompensation
231,PROMACTA,warnings and precautions,"hepatotoxicity, thrombotic complications, thromboembolic complications, portal vein thrombosis, hepatic decompensation, ascites, encephalopathy, indirect hyperbilirubinemia, liver injury, hepatic decompensation, cataracts"
232,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
233,BESIVANCE,warnings and precautions,"growth of resistant organisms, prolonged use, super-infection, bacterial conjunctivitis"
234,INLYTA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, renal impairment, hepatic impairment, hepatotoxicity, hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS (reversible posterior leukoencephalopathy syndrome), proteinuria, elevation of liver enzymes, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, hand-foot syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion, thrombosis, polycythemia, transient ischemic attack, hemoglobin decreased, lymphocytes decreased, platelets decreased, white blood cells decreased, creatinine increased, bicarbonate decreased, hypocalcemia, ALP increased, hyperglycemia, lipase increased, amylase increased, ALT increased, AST increased, hypernatremia, hypoalbuminemia, hyperkalemia, hypoglycemia, hyponatremia, hypophosphatemia, hemoglobin increased, hypercalcemia."
235,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, thyroid hormone replacement, Reversible Posterior Leukoencephalopathy Syndrome (RPLS), proteinuria, liver enzyme elevation, hepatic impairment, fetal harm, death"
236,NORTHERA,adverse reactions,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity (in the presence of severe renal impairment), increased toxicity (in the presence of moderate or severe hepatic impairment), hepatotoxicity, supine hypertension, hyperpyrexia, confusion, ischemic heart disease exacerbation, arrhythmias exacerbation, congestive heart failure exacerbation, headache, dizziness, nausea, hypertension, fatigue, falls, urinary tract infections, syncope"
237,NORTHERA,boxed warnings,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, supine hypertension"
238,NORTHERA,warnings and precautions,"supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, bronchial asthma, death"
239,ADCETRIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, abdominal pain, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, noninfectious pulmonary toxicity, pneumonitis, interstitial lung disease, ARDS, toxic epidermal necrolysis, Stevens-Johnson syndrome, tumor lysis syndrome, septic shock, supraventricular arrhythmia, urinary tract infection, pneumonia, bacteremia, sepsis, septic shock, embryo-fetal toxicity, death"
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, benzyl alcohol toxicity, Gasping Syndrome, hypotension, metabolic acidosis, kernicterus, increased radiation exposure, thyroid neoplasia, hypertension"
241,AFINITOR,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, non-infectious pneumonitis, angioedema, oral ulceration, renal failure, impaired wound healing, laboratory test alterations, hypercholesterolemia, hypertriglyceridemia, anemia, lymphopenia, neutropenia, thrombocytopenia, hyperglycemia, hypophosphatemia, stomatitis, mouth ulcers, oral mucositis, dehydration, pneumonia, gastroenteritis, aggression, agitation, amenorrhea, elevated partial thromboplastin time, acne, respiratory tract infection, pyrexia, fatigue, cough, diarrhea, nausea, vomiting, constipation, abdominal pain, asthenia, edema, rash, pruritus, dry skin, anorexia, headache, dysgeusia, arthralgia, back pain, pain in extremity, muscle spasms, insomnia, dyspnea, epistaxis, pneumonitis, hypertension, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, angioedema, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, dizziness, paresthesia, eyelid edema, conjunctivitis, deep vein thrombosis, renal failure, tachycardia, congestive cardiac failure, jaw pain, hemorrhage, cellulitis, elevated creatinine, death"
242,AMPYRA,all-concat,"seizures, anaphylaxis, urinary tract infections, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, confusional state"
243,AMYVID,all-concat,"Headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
244,APTIOM,all-concat,"suicidal behavior and ideation, serious dermatologic reactions, drug reaction with eosinophilia and systemic symptoms (DRESS), multiorgan hypersensitivity, anaphylactic reactions, angioedema, hyponatremia, neurological adverse reactions, drug induced liver injury, abnormal thyroid function tests, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, fever, rash, lymphadenopathy, eosinophilia, dizziness, disturbance in gait and coordination, ataxia, vertigo, balance disorder, gait disturbance, nystagmus, abnormal coordination, somnolence, fatigue, asthenia, malaise, hypersomnia, sedation, lethargy, cognitive dysfunction, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, visual changes, diplopia, blurred vision, impaired vision, jaundice, transaminase elevations, bilirubin elevations, serum T3 decrease, serum T4 decrease"
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
246,BELEODAQ,all-concat,"hematologic toxicity, infection, hepatotoxicity, tumor lysis syndrome, gastrointestinal toxicity, nausea, fatigue, pyrexia, anemia, vomiting, constipation, diarrhea, dyspnea, rash, peripheral edema, cough, thrombocytopenia, pruritus, chills, increased blood lactate dehydrogenase, decreased appetite, headache, infusion site pain, hypokalemia, prolonged QT, abdominal pain, hypotension, phlebitis, dizziness, pneumonia, sepsis, increased creatinine, multi-organ failure, febrile neutropenia, leukopenia, neutropenia, lymphopenia, embryo-fetal toxicity, death"
247,BENLYSTA,all-concat,"mortality, serious infections, malignancy, hypersensitivity reactions, anaphylaxis, infusion reactions, depression, progressive multifocal leukoencephalopathy (PML), leukopenia, gastroenteritis viral, fatal anaphylaxis, death, infections, pneumonia, urinary tract infection, cellulitis, bronchitis, influenza, upper respiratory tract infection, sinusitis, nasopharyngitis, cystitis, cardiovascular disease, suicide, malignancies, non-melanoma skin cancers, bradycardia, myalgia, headache, rash, urticaria, hypotension, skin reactions, psychiatric events, insomnia, anxiety, immunization issues, concomitant use with other biologic therapies or intravenous cyclophosphamide"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue, throat"
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
250,BLINCYTO,all-concat,"cytokine release syndrome, neurological toxicities, infections, tumor lysis syndrome, neutropenia, febrile neutropenia, elevated liver enzymes, leukoencephalopathy, preparation and administration errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, Staphylococcal bacteremia, anemia, thrombocytopenia, leukopenia, diarrhea, abdominal pain, vomiting, fatigue, chills, chest pain, cytokine release syndrome, bacterial infections, fungal infections, viral infections, increased alanine aminotransferase, increased aspartate aminotransferase, hypomagnesemia, hyperglycemia, decreased appetite, hypophosphatemia, back pain, pain in extremity, bone pain, arthralgia, dizziness, insomnia, cough, dyspnea, hypotension, hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, death"
251,BOSULIF,all-concat,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, embryofetal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, febrile neutropenia, pericardial effusion, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, pain, hepatotoxicity, abnormal hepatic function, liver injury, drug hypersensitivity, pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption"
252,BREO,all-concat,"asthma-related death, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, Candida albicans infection, pneumonia, immunosuppression, hypercorticism, adrenal suppression, bone mineral density reduction, paradoxical bronchospasm, cardiovascular effects, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, growth reduction, oropharyngeal pain, dysphonia, cough, bronchitis, sinusitis, influenza, back pain, arthralgia, pharyngitis, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, muscle spasms, tremor, nervousness, palpitations, tachycardia, anaphylaxis, angioedema, rash, urticaria, death"
253,CARBAGLU,all-concat,"'infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia, brain injury, death'"
254,CERDELGA,all-concat,"'fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias'"
255,CHOLINE,all-concat,"injection site reaction, imaging errors, allergic reactions, radiation risk, tissue inflammation, prostatic hyperplasia, false positive results, false negative results, anaphylaxis, cancer risk"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, psoriasis, sarcoidosis, disseminated tuberculosis, extrapulmonary tuberculosis, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, Legionella infection, Listeria infection, hepatosplenic T-cell lymphoma, acute leukemia, chronic leukemia, congestive heart failure, angioedema, serum sickness, syncope"
257,CLEVIPREX,all-concat,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation, pulmonary shunting, negative inotropic effects, heart failure, rebound hypertension, pheochromocytoma"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, hypersensitivity reactions, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, aspartate aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, bullous eruption, QT prolongation, recrudescence"
259,COMETRIQ,all-concat,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, asthenia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, pneumonia, septicemia, cardiac arrest, respiratory failure, death"
260,DALVANCE,all-concat,"nausea, vomiting, diarrhea, headache, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, anaphylactic reactions, skin reactions, ""Red-Man Syndrome"""
261,DATSCAN,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, skin erythema"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, site inflammation, extravasation, warmth, bradycardia, tachycardia, arrhythmia, anaphylactoid reactions, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, death"
264,DUAVEE,all-concat,"cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial cancer, stroke, deep vein thrombosis, probable dementia, gallbladder problems, loss of vision, high blood pressure, increased fats in blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of mouth or tongue, worsening of asthma, diabetes, epilepsy, migraines, porphyria, lupus, liver problems, blood clots, cancer of the lining of the uterus, breast cancer, cancer of the ovary, dementia, visual abnormalities, retinal vascular thrombosis, elevated blood pressure, severe hypertriglyceridemia, cholestatic jaundice, hypothyroidism, hypocalcemia, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance, death (due to all-cause mortality being mentioned)"
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis, glaucoma, delayed healing, bleb formation, bacterial infections, viral infections, fungal infections"
266,DYSPORT,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, breathing difficulty, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, vertigo, gait disturbance, hypertonia, sensation of heaviness, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, cough, hypertension, bronchitis, pharyngolaryngeal pain, contact dermatitis, injection site swelling, injection site bruising, injection site erythema, injection site haematoma, dysphagia, death"
267,EDARBI,all-concat,"diarrhea, hypotension, orthostatic hypotension, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, nausea, rash, pruritus, angioedema, death"
268,ELIQUIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, thrombotic events, bleeding, spinal/epidural anesthesia or puncture, hemorrhagic stroke, gastrointestinal bleed, fatal bleeding, intracranial bleeding, non-intracranial bleeding, hypersensitivity reactions, syncope, deep vein thrombosis, nausea, anemia, contusion, hemorrhage, postprocedural hemorrhage, transaminases increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, thrombocytopenia, hypotension, epistaxis, gastrointestinal hemorrhage, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, operative hemorrhage, gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, hematemesis, melena, anal hemorrhage, wound hemorrhage, postprocedural hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, severe hepatic impairment, end-stage renal disease, complete gastrointestinal obstruction, pancreatic anastomosis, gastric anastomosis"
270,EOVIST,all-concat,"nephrogenic systemic fibrosis, hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions, dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders, fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, death"
271,ERWINAZE,all-concat,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, hyperbilirubinemia, hyperlipidemia, ketoacidosis, CNS events, allergic reactions, thrombotic events, hemorrhagic events, hepatobiliary disorders, pancreatic disorders, hyperglycemia, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, sagittal sinus thrombosis, pulmonary embolism, fibrinogen decrease, protein C activity decrease, protein S activity decrease, anti-thrombin III decrease"
272,EYLEA,all-concat,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal tear, retinal detachment, endophthalmitis"
273,FANAPT,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, death, cerebrovascular accidents, transient ischemic attacks, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, tardive dyskinesia, hyperglycemia, diabetes mellitus, dyslipidemia, seizures, syncope, leukopenia, neutropenia, agranulocytosis, hyperprolactinemia, gynecomastia, galactorrhea, priapism, cognitive impairment, motor impairment"
274,FARXIGA,all-concat,"hypotension, renal function impairment, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer, volume depletion, dehydration, hypovolemia, orthostatic hypotension, renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions, angioedema, urticaria, hematocrit increase, serum inorganic phosphorus increase, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, elevated ALT, decreased plasma zinc concentrations, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, laryngeal attacks"
277,FULYZAQ,all-concat,"upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin, nausea, back pain, arthralgia, urinary tract infection, nasopharyngitis, musculoskeletal pain, hemorrhoids, giardiasis, anxiety, increased alanine aminotransferase, abdominal distension, abdominal pain, acne, increased aspartate aminotransferase, increased conjugated bilirubin, increased unconjugated blood bilirubin, constipation, depression, dermatitis, dizziness, dry mouth, dyspepsia, gastroenteritis, herpes zoster, nephrolithiasis, pain in extremity, pollakiuria, procedural pain, seasonal allergy, sinusitis, decreased white blood cell count"
278,GADAVIST,all-concat,"nephrogenic systemic fibrosis, hypersensitivity reactions, headache, nausea, dizziness, dysgeusia, feeling hot, injection site reactions, vomiting, rash, pruritus, erythema, anaphylactoid reactions, dyspnea, paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
279,GILENYA,all-concat,"'bradyarrhythmia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, bronchitis, herpes zoster, tinea versicolor, bradycardia, migraine, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, basal cell carcinoma, dizziness, pneumonia, eczema, pruritus, ischemic strokes, hemorrhagic strokes, peripheral arterial occlusive disease, lymphomas, death'"
280,GILOTRIF,all-concat,"diarrhea, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, embryofetal toxicity, peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, rash, dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity, ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, hypokalemia, aspartate aminotransferase increased, pancreatitis, bullous, blistering, exfoliating lesions, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, liver test abnormalities, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, abortions, death"
281,GRANIX,all-concat,"splenic rupture, acute respiratory distress syndrome (ARDS), serious allergic reactions, sickle cell crisis, capillary leak syndrome, tumor growth stimulatory effects on malignant cells, bone pain, leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, cutaneous vasculitis, thrombocytopenia, anaphylaxis, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, death"
282,HALAVEN,all-concat,"Neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, QT interval prolongation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, embryo-fetal toxicity, death (due to complications of febrile neutropenia), increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash"
283,HORIZANT,all-concat,"somnolence, sedation, dizziness, RLS, PHN, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts, behaviors, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, withdrawal seizure, tumorigenic potential, pancreatic acinar cell adenoma, carcinoma, breast cancer, brain tumor, lung cancer, adrenal tumor, non-Hodgkin's lymphoma, endometrial carcinoma in situ, prostate cancer"
284,ILARIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, upper respiratory tract infections, serious infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, rhinitis, tonsillitis, sinusitis, urinary tract infection, gastroenteritis, viral infection, hypersensitivity, immunogenicity, white blood cell decrease, neutrophil decrease, platelet decrease, transaminase elevation, bilirubin elevation, tuberculosis, immunosuppression, malignancies, macrophage activation syndrome"
285,IMBRUVICA,all-concat,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, embryo-fetal toxicity, peripheral neuropathy, anaphylactic shock, urticaria, angioedema, death"
286,INLYTA,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS, proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion, thrombosis, polycythemia, transient ischemic attack, death"
287,INTELENCE,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, severe skin reactions, hypersensitivity reactions, rash, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, rhabdomyolysis, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS, hepatic failure, death"
288,INVOKANA,all-concat,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C, increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, asthenia, pancreatitis, erythema, rash, pruritus, urticaria, angioedema, photosensitivity reactions, volume depletion-related adverse reactions, falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, candidal balanitis, balanoposthitis, phimosis, severe hypoglycemia, increases in serum potassium, increases in serum magnesium, increases in serum phosphate, increases in hemoglobin, decreases in bone mineral density"
289,JARDIANCE,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C, increased urination, dyslipidemia, arthralgia, nausea, thirst, volume depletion, dehydration, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increase, eGFR decrease, phimosis, asymptomatic bacteriuria, cystitis, upper respiratory tract infection, vulvovaginal mycotic infection, vaginal infection, vulvitis, vulvovaginal candidiasis, genital infection, genital candidiasis, genital infection fungal, genitourinary tract infection, vulvovaginitis, cervicitis, urogenital infection fungal, vaginitis bacterial, balanoposthitis, balanitis, scrotal abscess, penile infection, hematocrit increase"
290,JEVTANA,all-concat,"bone marrow suppression, hypersensitivity reactions, gastrointestinal adverse reactions, renal failure, embryo-fetal toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, febrile neutropenia, infections, ventricular fibrillation, cerebral hemorrhage, arrhythmia, peripheral edema, mucosal inflammation, pain, urinary tract infection, weight decreased, dehydration, muscle spasms, dizziness, headache, dysuria, hypotension, gastritis, intestinal obstruction, death"
291,JUBLIA,all-concat,"Ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash, urticaria"
293,KALYDECO,all-concat,"transaminase elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, infections, infestations, rhinitis, aspartate aminotransferase increased, bacteria in sputum, blood glucose increased, hepatic enzyme increased, musculoskeletal and connective tissue disorders, arthralgia, musculoskeletal chest pain, myalgia, nervous system disorders, sinus headache, respiratory, thoracic and mediastinal disorders, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, skin and subcutaneous tissue disorders, acne, cataracts"
294,KYPROLIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, cardiac toxicities, acute renal failure, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, embryo-fetal toxicity, cardiac failure, myocardial infarction, myocardial ischemia, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, pulmonary arterial hypertension, hypertensive crisis, hypertensive emergency, infusion site reaction, multi-organ failure, febrile neutropenia, lymphopenia, cardiac arrest, congestive heart failure, cataract, vision blurred, abdominal pain, abdominal pain upper, dyspepsia, toothache, chills, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, tumor lysis syndrome, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal failure, renal failure acute, renal impairment, dysphonia, epistaxis, oropharyngeal pain, pulmonary embolism, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, death"
295,LUMIZYME,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, rash, pyrexia, flushing, feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension, increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, bronchospasm, throat tightness, hypotension, angioedema, face edema, chest pain, wheezing, convulsions, pruritus, peripheral coldness, restlessness, nervousness, back pain, paresthesia, immune-mediated reactions, proteinuria, nephrotic syndrome, necrotizing skin lesions, flu-like illness, arthralgia, pain, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, cardiac arrhythmia, sudden cardiac death, supraventricular tachycardia, local swelling, diarrhea, pruritus, papular rash, edema, peripheral, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, hyperparathyroidism, anaphylactic reactions, severe hypersensitivity reactions, acute exacerbation of cardiac or respiratory compromise, fluid overload, cardiac hypertrophy, ventricular arrhythmias, bradycardia, cardiac resuscitation, defibrillation, loss of motor function, ventilator dependence, death, inhibitory antibody activity, IgE antibodies, mediators of anaphylaxis."
296,MULTAQ,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, creatinine increase, atrial flutter, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, death, stroke, cardiovascular death, arrhythmic death, heart failure events, stroke risk, worsening heart failure, hepatocellular liver injury, acute liver failure, renal impairment, renal failure, pre-renal azotemia, acute renal failure, teratogenic effects"
297,NATAZIA,all-concat,"'serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, migraines, menstrual disorders, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, mood changes, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, acne, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, pulmonary emboli, deep vein thrombosis, cerebral thrombosis, myocardial infarction, stroke, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis, thrombotic event, arterial thromboses, thromboembolic disease, cerebrovascular events, hemorrhagic strokes, retinal vein thrombosis, carcinoma of the breasts, cervical cancer, intraepithelial neoplasia, liver cancers, hepatocellular carcinoma, hepatic adenomas, intra-abdominal hemorrhage, COC-related cholestasis, gallbladder disease, carbohydrate and lipid metabolic effects, pancreatitis, bleeding irregularities, breakthrough bleeding, spotting, amenorrhea, oligomenorrhea, intracyclic bleeding, depression, hereditary angioedema, symptoms of angioedema'"
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis"
299,NEURACEQ,all-concat,"erythema, irritation, pain, image interpretation errors, radiation risk"
300,NORTHERA,all-concat,"supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, falls, urinary tract infections, syncope, allergic reactions"
301,NULOJIX,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, post-transplant lymphoproliferative disorder (PTLD), malignancies, serious infections, progressive multifocal leukoencephalopathy (PML), polyoma virus nephropathy, cytomegalovirus infection, tuberculosis, bacterial infections, viral infections, fungal infections, protozoal infections, infusion-related reactions, proteinuria, immunogenicity, new-onset diabetes after transplantation (NODAT), hypertension, dyslipidemia, urinary tract infection, upper respiratory infection, nasopharyngitis, cytomegalovirus infection, influenza, bronchitis, diarrhea, constipation, nausea, vomiting, abdominal pain, hyperkalemia, hypokalemia, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, graft dysfunction, peripheral edema, pyrexia, anemia, leukopenia, hematuria, dysuria, renal tubular necrosis, cough, dyspnea, blood creatinine increased, arthralgia, back pain, headache, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, chronic allograft nephropathy, complications of transplanted kidney, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death"
302,ONFI,all-concat,"'somnolence, sedation, potentiation of sedation, withdrawal symptoms, serious dermatological reactions, physical dependence, psychological dependence, suicidal behavior, suicidal ideation, vomiting, constipation, dysphagia, pyrexia, irritability, fatigue, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, lethargy, drooling, ataxia, psychomotor hyperactivity, dysarthria, aggression, insomnia, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial edema, lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis'"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, abdominal pain, fatigue, dyspepsia, insomnia, back pain, frequent bowel movements, depression, bronchitis, tooth abscess, folliculitis, sinus headache, death"
304,PICATO,all-concat,"ophthalmic adverse reaction, hypersensitivity reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis"
305,POTIGA,all-concat,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior, suicidal ideation, withdrawal seizures, vision changes, retinal pigmentary abnormalities, urologic symptoms, confusional state, psychotic symptoms, hallucinations, QT prolongation, depression, mood changes, behavior changes, increased seizure frequency, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy, nausea, constipation, dyspepsia, fatigue, asthenia, influenza, weight increased, memory impairment, tremor, vertigo, abnormal coordination, disturbance in attention, gait disturbance, aphasia, dysarthria, balance disorder, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes"
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, dyspepsia, nausea, upper abdominal pain, diarrhea, major bleeding, intracranial hemorrhage, hemorrhagic stroke, gastrointestinal bleeding, fatal bleeding, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, myocardial infarction, esophageal ulcer, thrombocytopenia, angioedema, death"
307,PRISTIQ,all-concat,"hypersensitivity, suicidal thoughts, behaviors, serotonin syndrome, elevated blood pressure, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, male sexual function disorders, blood pressure increased, dry mouth, vomiting, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, insomnia, nervousness, abnormal dreams, urinary hesitation, yawning, hyperhidrosis, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, Stevens-Johnson syndrome, death (if considering the boxed warning regarding suicidal thoughts and behaviors as a fatal event)."
308,PROLIA,all-concat,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, pancreatitis, new malignancies, death"
309,PROMACTA,all-concat,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, alopecia, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, headache, hyperbilirubinemia, cataract, nausea, pain in extremity, dyspnea, dizziness, febrile neutropenia, abdominal pain, ecchymosis, muscle spasms, transaminases increased, arthralgia, rhinorrhea, thrombotic microangiopathy, acute renal failure"
310,QUTENZA,all-concat,"application-associated pain, increase in blood pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
311,SAPHRIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, dementia-related psychosis, neuroleptic malignant syndrome, tardive dyskinesia, metabolic changes, hypersensitivity reactions, oral ulcers, blisters, peeling, sloughing, inflammation, orthostatic hypotension, syncope, hemodynamic effects, leukopenia, neutropenia, agranulocytosis, QT interval prolongation, hyperprolactinemia, seizures, cognitive impairment, motor impairment, body temperature regulation, suicide, dysphagia, cerebrovascular adverse events, stroke, transient ischemic attack, death"
312,SIMPONI,all-concat,"'serious infections, malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, liver enzyme elevations, autoimmune disorders, autoantibodies, administration reactions, immunogenicity, infections and infestations, vascular disorders, skin and subcutaneous disorders, general disorders and administration site conditions, blood and lymphatic disorders, superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, investigations, nervous system disorders, gastrointestinal disorders, neoplasm benign and malignant, melanoma, immune system disorders, serious systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, respiratory, thoracic and mediastinal disorders, interstitial lung disease, skin exfoliation, bullous skin reactions, congestive heart failure, demyelinating disorders, hematologic cytopenias, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia, hypersensitivity reactions'"
313,SIRTURO,all-concat,"Increased mortality, QT Prolongation, Hepatotoxicity, Drug Interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased, death"
314,STENDRA,all-concat,"'headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection, bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, non-arteritic anterior ischemic optic neuropathy (NAION), priapism, sudden loss of vision, sudden decrease or loss of hearing, tinnitus, prolonged erection, anatomical deformation of the penis, angulation, cavernosal fibrosis, Peyronie's disease, sickle cell anemia, multiple myeloma, leukemia, color vision changes'"
315,STRIBILD,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, lactic acidosis, severe hepatomegaly with steatosis, severe acute exacerbations of hepatitis B, new onset or worsening renal impairment, bone effects of tenofovir DF, immune reconstitution syndrome, ocular icterus, diarrhea, flatulence, nausea, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, abdominal pain, hepatic steatosis, hepatitis, increased liver enzymes, skin discoloration, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, proteinuria, polyuria, asthenia, death"
316,TAFINLAR,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, new primary malignancies, tumor promotion, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, embryofetal toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, non-cutaneous malignancies, deep vein thrombosis, pulmonary embolism, retinal vein occlusion, interstitial lung disease, retinal pigment epithelial detachment, uveitis, iritis, death"
317,TANZEUM,all-concat,"thyroid C-cell tumors, acute pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, pneumonia, atrial fibrillation, atrial flutter, appendicitis, liver enzyme abnormalities, gamma glutamyltransferase increase, heart rate increase, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus"
318,TECFIDERA,all-concat,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albuminuria, erythema, dyspepsia, increased aspartate aminotransferase, eosinophilia, death"
319,TEFLARO,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, direct Coombs' test seroconversion, diarrhea, nausea, rash, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, hypersensitivity, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
320,TIVICAY,all-concat,"hypersensitivity reactions, serum liver biochemistries effects, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, suicidal completion, renal impairment, pruritus, rash, depression, abnormal dreams, dizziness, nausea, diarrhea, vertigo, liver injury, transaminase elevations, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia, tuberculosis, Graves' disease, polymyositis, Guillain-Barre syndrome"
321,TOVIAZ,all-concat,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
322,TREANDA,all-concat,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, embryo-fetal toxicity, death, hypersensitivity, pyrexia, nausea, vomiting, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, hypertension, hypertensive crisis, asthenia, fatigue, malaise, weakness, dry mouth, somnolence, mucosal inflammation, neutropenic sepsis, diffuse alveolar hemorrhage, pneumonia, opportunistic infection, CMV infection, sepsis, septic shock, febrile neutropenia, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, dysgeusia, taste disorder, atypical pneumonia, herpes zoster, erythema, dermatitis, skin necrosis, anaphylactic reactions, anaphylactoid reactions, pruritus, toxic skin reactions, bullous exanthema, toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SJS), myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, bronchial carcinoma, erythema, swelling, pain, infection, necrosis, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights, hyperuricemia, hyperglycemia, elevated creatinine, hyponatremia, hypocalcemia, tachycardia, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal distension, edema peripheral, chest pain, infusion site pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, oral candidiasis, nasopharyngitis, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension."
323,TRULICITY,all-concat,"thyroid C-cell tumors, pancreatitis, hypoglycemia, hypersensitivity reactions, renal impairment, severe gastrointestinal disease, nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, fatigue, constipation, flatulence, abdominal distension, gastroesophageal reflux disease, eructation, sinus tachycardia, systemic hypersensitivity, injection-site reactions, PR interval prolongation, first degree atrioventricular block, amylase increase, lipase increase"
324,TUDORZA,all-concat,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, ocular irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation, neonatal toxicity, gasping syndrome, metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, contact dermatitis"
326,ULORIC,all-concat,"Liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, twitching, tightness, weakness, musculoskeletal pain, stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure (some fatal), jaundice, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, gout flare, cardiovascular thromboembolic events, myocardial infarction, stroke, death"
327,VICTRELIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, increased toxicity, hepatotoxicity, fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, agranulocytosis, thrombocytopenia, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, diarrhea, vomiting, dry mouth, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash"
328,VIMIZIM,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity, hepatotoxicity, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, acute respiratory complications, spinal or cervical cord compression"
329,VIZAMYL,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, infections, opportunistic infections, tumor lysis syndrome, increased toxicity (in the presence of severe renal impairment), increased toxicity (in the presence of moderate or severe hepatic impairment), hepatotoxicity, flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure"
330,VORAXAZE,all-concat,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea, vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction, renal failure, paresthesia, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
331,XALKORI,all-concat,"hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, embryofetal toxicity, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, neuropathy, rash, renal cyst, syncope, neutropenia, lymphopenia, hypophosphatemia, ALT elevation, AST elevation, pneumonia, ILD, acute respiratory distress syndrome, arrhythmia, respiratory failure, sepsis, hypokalemia, hepatic failure, death"
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, cervical dystonia, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia, anaphylaxis, serum sickness, urticaria, soft tissue edema, corneal exposure, corneal ulceration, ectropion, ptosis, death"
333,XIAFLEX,all-concat,"tendon ruptures, serious injury, injected extremity, tendon ruptures, Peyronie's disease, corporal rupture, penile fracture, severe penile hematoma, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, sensation, edema peripheral, swelling, contusion, injection site hemorrhage, injection site reaction, pain, tenderness, injection site swelling, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, finger extension procedures, blood blister, injection site hematoma, ecchymosis, penile injury, hypersensitivity reactions, anaphylaxis, abnormal coagulation, flexor tendon rupture, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality, skin laceration, tear, penile ""popping"" sounds, sensations, localized pruritus, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe injection site hematoma, IgE-anti-drug antibodies, bleeding, abnormal coagulation, ecchymosis, contusion, injection site hemorrhage, penile hematoma, penile ecchymosis, coagulation disorders, anticoagulants, low-dose aspirin"
334,XTANDI,all-concat,"seizure, asthenia, fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness, vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract infection, lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, ALT elevation, bilirubin elevation, infections, sepsis, fall-related injuries, joint injuries, hematomas, hypertensive crisis, death"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, gastrointestinal disorders, skin and subcutaneous tissue disorders, general disorders and administration site conditions, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), immune-mediated reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, Guillain-Barre syndrome, myasthenia gravis, hypothyroidism, hyperthyroidism, Cushing's syndrome, hypophysitis, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, death"
336,ZERBAXA,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis, death"
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, death"
338,ZYKADIA,all-concat,"severe or persistent gastrointestinal toxicity, hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, hyperglycemia, bradycardia, pancreatitis, embryofetal toxicity, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, vision disorder, prolonged QT interval, hemoglobin decreased, alanine transaminase increased, aspartate transaminase increased, creatinine increased, glucose increased, phosphate decreased, lipase increased, bilirubin increased, death"
339,ZYTIGA,all-concat,"hypertension, hypokalemia, fluid retention, mineralocorticoid excess, adrenocortical insufficiency, hepatotoxicity, fatigue, joint swelling, discomfort, edema, hot flush, diarrhea, vomiting, cough, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain, cardiac failure, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, hypernatremia, non-infectious pneumonitis, myopathy, rhabdomyolysis, death"
